PDLI - PDL BioPharma, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5369.32M
Enterprise Value 398.97M
Trailing P/E N/A
Forward P/E 121.17
PEG Ratio (5 yr expected) 1-0.31
Price/Sales (ttm)3.13
Price/Book (mrq)0.52
Enterprise Value/Revenue 30.84
Enterprise Value/EBITDA 6403.96

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2017
Most Recent Quarter (mrq)Jun 30, 2018


Profit Margin -57.23%
Operating Margin (ttm)-24.34%

Management Effectiveness

Return on Assets (ttm)-1.60%
Return on Equity (ttm)-8.83%

Income Statement

Revenue (ttm)118.16M
Revenue Per Share (ttm)0.79
Quarterly Revenue Growth (yoy)-39.60%
Gross Profit (ttm)109.45M
Net Income Avi to Common (ttm)-67.63M
Diluted EPS (ttm)-0.45
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)395.65M
Total Cash Per Share (mrq)2.72
Total Debt (mrq)120.94M
Total Debt/Equity (mrq)16.97
Current Ratio (mrq)11.12
Book Value Per Share (mrq)4.88

Cash Flow Statement

Operating Cash Flow (ttm)-40.74M
Levered Free Cash Flow (ttm)-12.15M

Trading Information

Stock Price History

Beta (3Y Monthly) -0.03
52-Week Change 3-27.07%
S&P500 52-Week Change 37.95%
52 Week High 33.55
52 Week Low 32.25
50-Day Moving Average 32.50
200-Day Moving Average 32.62

Share Statistics

Avg Vol (3 month) 31.27M
Avg Vol (10 day) 3970.8k
Shares Outstanding 5145.4M
Float 131.75M
% Held by Insiders 12.72%
% Held by Institutions 189.32%
Shares Short (Sep 28, 2018) 418.32M
Short Ratio (Sep 28, 2018) 410.79
Short % of Float (Sep 28, 2018) 412.37%
Short % of Shares Outstanding (Sep 28, 2018) 412.60%
Shares Short (prior month Aug 31, 2018) 418.58M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jun 13, 2016
Ex-Dividend Date 4Jun 2, 2016
Last Split Factor (new per old) 22/1
Last Split Date 3Oct 10, 2001